Imagen Technologies

AI-enabled teleradiology platform combining remote radiologist coverage with clinical tools and administrative support.

Website: https://imagen.ai/

Cover Block

Public sources

Field Value
Company Imagen Technologies
Tagline AI-enabled teleradiology platform combining remote radiologist coverage with clinical tools and administrative support.
Headquarters New York, New York, USA [Crunchbase]
Founded 2015 [Crunchbase]
Stage Growth / Late Stage
Business model B2B
Industry Healthtech
Technology AI / Machine Learning
Geography North America
Growth profile Venture Scale
Founding team Co-Founders (2) [Crunchbase, retrieved 2026]
Founders Robert Lindsey, Alex Dresner [Crunchbase, retrieved 2026]
Funding label $100M+
Total disclosed funding ~$200,000,000 [Imagen, November 2026]; [CB Insights, retrieved 2026]; [Tracxn, retrieved 2026]; [Whiteford Research Biobase, retrieved 2026]

Links

Public sources

Executive Summary

PUBLIC Imagen Technologies is building an AI-enabled teleradiology platform, and it merits attention because the company appears to be scaling a physician-led service model that pairs remote radiologist coverage with proprietary workflow and diagnostic tools in a part of healthcare where staffing, turnaround time, and diagnostic quality remain live operational issues [Imagen, retrieved Unknown] [Imagen Technologies Careers, November 2026]. Founded in 2015 and based in New York, the company presents itself less as a single-algorithm vendor than as a full-stack imaging partner, combining subspecialist reads, administrative support, and FDA-cleared AI tools; that operating model is the most important point to track because it can be harder to copy than point-solution software if the service layer holds up at scale [Crunchbase, retrieved Unknown] [Imagen, retrieved Unknown]. Public materials indicate the platform reads more than 2 million studies annually, while a third-party profile says Imagen interprets more than 2 million studies across 28 states, which is directionally supportive but still relies heavily on company-originated claims [Imagen, retrieved Unknown] [Ventureburn].

The founding record is somewhat clearer than the commercial record: Robert Lindsey is identified as co-founder and CTO in both Crunchbase and LinkedIn-based references, while Alex Dresner is identified as co-founder and CEO in Crunchbase [Crunchbase, retrieved Unknown] [Andrew O'Connor - LinkedIn, retrieved 2026]. On product, Imagen's differentiation rests on integrating radiologist labor, imaging workflows, and in-house AI into one offering for hospitals, health systems, and physician groups, rather than selling software into an external radiology stack and hoping for adoption later [Imagen, retrieved Unknown] [MedIndexer, retrieved 2026]. That can support tighter quality control and deeper workflow embed, but it also means investors should underwrite operational execution, clinician recruiting, and customer retention alongside software capability [Imagen, retrieved Unknown].

Capital formation has been meaningful. Company materials say Imagen has raised over $200 million, and the structured round history includes a $14.3 million Series A in March 2017 led by Casdin Capital, a $32 million round in December 2024, and a $100 million financing announced in November 2026; Google Ventures also appears in company and profile materials as an investor [Imagen Technologies Careers, November 2026] [CB Insights] [Multiples] [Tracxn] [Imagen, November 2026]. The business model is B2B, with national diagnostic imaging services and software sold into provider organizations, but the next 12 to 18 months likely turn on whether Imagen can convert expansion claims into independently visible customer proof points, sustain recruiting depth in radiology and technical roles, and show that its AI-enabled practice model scales beyond company-reported service metrics such as retention, turnaround time, and adherence [Imagen Technologies Careers, November 2026] [Imagen, retrieved Unknown].

Company-stated, unverified -- This section relies materially on company website and recruiting materials, with partial corroboration from Crunchbase, LinkedIn-based references, and third-party databases.

Taxonomy Snapshot

Axis Value
Stage Growth / Late Stage
Business Model B2B
Industry / Vertical Healthtech
Technology Type AI / Machine Learning
Geography North America
Growth Profile Venture Scale
Founding Team Co-Founders (2)
Funding $100M+ total disclosed, approximately $200,000,000

How the Company Got Here

PUBLIC

Imagen Technologies was founded in 2015 and is based in New York, New York, according to Crunchbase and the company website [Crunchbase], [Imagen]. Public materials consistently describe the business in plain operational terms: an AI-powered radiology and diagnostic imaging platform that pairs subspecialist radiologists with software and workflow infrastructure for hospitals, health systems, and physician groups [Imagen], [Crunchbase]. The corporate framing matters because Imagen appears to be selling a service layer around imaging interpretation, not only a point solution algorithm, which shapes both its go-to-market motion and the evidence investors should expect to see in customer adoption [Imagen].

The founder record is narrower than the marketing surface. Crunchbase identifies Robert Lindsey as co-founder and CTO and Alex Dresner as co-founder and CEO [Crunchbase]. The company website positions Imagen as a physician-led, AI-enabled diagnostic imaging platform and, by August 2023, disclosed that it had achieved HITRUST Risk-based, 2-year Certification, a useful milestone for a healthcare infrastructure vendor handling sensitive clinical workflows [Imagen, August 2023].

Chronology beyond the founding year is partly visible through financing disclosures rather than operating announcements. Crunchbase shows an early financing history that includes a 2016 seed round and a March 2017 Series A, while the company stated in November 2026 that it had raised $100 million in additional capital [Crunchbase], [Imagen, November 2026]. Taken together, the public record supports a picture of a company that began in radiology workflow and has since tried to build a broader AI-enabled practice layer around that base, though the legal-entity detail and several operating milestones are not established in the cited public filings and profiles used here [Crunchbase], [Imagen].

Lightly corroborated -- Confirmed primarily by Crunchbase and company website materials, with partial chronology support from an Imagen certification announcement.

Product and Technology

Sources and analysis The product story here is less about a single imaging algorithm and more about the operating model wrapped around it. Imagen describes itself as an AI-powered radiology and diagnostic imaging platform, and its public materials position the company as an AI-enabled teleradiology provider for health systems and physician groups rather than a pure software vendor [Imagen]. On its website, the company says it combines subspecialist radiologists, imaging technology, and AI to improve diagnostic speed and accuracy, with reported operating metrics that include 99.5% service adherence, less than 1% addendum rate, a 17-minute average STAT turnaround time, more than 2 million studies read annually, and 200-plus specialists [Imagen].

The architecture that can be verified publicly appears to include three layers. First, there is remote clinical coverage by board-certified radiologists, including overnight reads and 24/7 operational support, as described in recruiting materials [Imagen Technologies, January 2026]. Second, there are workflow and quality tools that the company says are built around a physician-led practice, including FDA-cleared AI software and internal report-quality monitoring [Imagen; Imagen AI, retrieved 2026]. Third, the company markets administrative and integration support around the core read workflow, including suspecting-tool integration and broader diagnostic imaging support for hospitals, clinics, and independent practices [Imagen; MedIndexer, retrieved 2026]. Public evidence also supports at least one regulatory marker: Imagen announced FDA clearance for Aorta-CAD, and the company separately disclosed HITRUST Risk-based, 2-year Certification in August 2023 [Imagen; Imagen, August 2023].

The technical stack itself is only partly visible from public artifacts, so any narrower read has to stay conditional. Verified Market Research describes Imagen's software as using deep learning and cloud-based radiology workflows, while a Staff Data Engineer opening points to an internal AI data platform [Verified Market Research, retrieved 2026] [Imagen Technologies, October 2025]. Beyond that, infrastructure details are best treated as limited public visibility, with cloud workflow and data-platform language best read as tech-stack signals rather than a full disclosed architecture (inferred from job postings) [Verified Market Research, retrieved 2026] [Imagen Technologies, October 2025].

Company-stated, unverified -- This section relies materially on company website, company careers pages, and company-issued announcements, with only partial third-party corroboration from MedIndexer and Verified Market Research.

Where the Demand Sits

PUBLIC

This market matters now because Imagen sits at the intersection of two durable pressures in U.S. care delivery: imaging volumes keep rising, while providers still need faster, more consistent radiology capacity across distributed sites [Verified Market Research, retrieved 2026] [Imagen Technologies, January 2026].

The hard part is that the public record here is thinner than the company narrative. No named third-party TAM, SAM, or SOM study specific to Imagen’s exact category appears in the supplied evidence, so any market sizing has to be treated as analogous rather than directly on-point. The closest public descriptions frame Imagen as an AI-driven diagnostic imaging and teleradiology platform serving hospitals, clinics, and teleradiology providers, with software that integrates deep learning and cloud-based radiology workflows [Verified Market Research, retrieved 2026]. That places the company across at least three overlapping spend pools: outsourced or distributed radiology interpretation, radiology workflow software, and AI-assisted imaging tools.

Public evidence also suggests the market is broader than a single software budget line. Imagen presents itself as an AI-powered radiology and diagnostic imaging platform, while its recruiting materials describe remote board-certified radiologists, overnight coverage, AI tooling, and 24/7 operational support [Imagen, retrieved Unknown] [Imagen Technologies, January 2026]. In practice, that implies demand can come from labor shortages, after-hours coverage needs, subspecialty access gaps, and workflow modernization, not only from a hospital CIO buying an algorithm.

Market frame What public sources support Relevance to Imagen
AI diagnostic imaging platforms AI-driven image interpretation and workflow software for hospitals, clinics, and teleradiology providers [Verified Market Research, retrieved 2026] Directly relevant to Imagen's software and AI tooling
Teleradiology services Remote radiologist interpretation, including overnight coverage, with operational support [Imagen Technologies, January 2026] Directly relevant to Imagen's physician-led reading model
Imaging operations enablement Administrative support, workflow integration, and care-gap review within provider workflows [Imagen, retrieved Unknown] Relevant to Imagen's service layer beyond image reading

The table points to a market definition issue that matters for underwriting. Imagen does not read like a pure imaging-AI vendor or a plain staffing intermediary. Based on the cited public materials, the business appears to bundle clinical labor, software, and operations into one offering, which can enlarge wallet share if adoption works, but also makes benchmarking against a single market report less precise [Imagen, retrieved Unknown] [Verified Market Research, retrieved 2026].

Demand drivers are clearer than market size. The company website emphasizes turnaround time, diagnostic quality, and retention metrics, including 17-minute average STAT turnaround time, more than 2 million studies read annually, and 200-plus specialists, though these are company claims rather than independently reported operating data [Imagen, retrieved Unknown]. Even with that caveat, the value proposition maps to an evident provider need: radiology groups and health systems want faster reads and access to subspecialists without building every capability locally [Imagen, retrieved Unknown] [MedIndexer, retrieved 2026].

There is also a geographic expansion signal in the company materials. Imagen's careers page says the platform expanded across 22 states and 2.7 million patients in 2025, with a target of more than 35 states and over 5 million patients annually by 2027 [Imagen Technologies Careers, November 2026]. Those figures are company-supplied and should not be treated as third-party validation, but they do indicate that management sees demand as national rather than niche, and that the go-to-market motion likely depends on multi-state operations, licensure, and workflow standardization.

Adjacent and substitute markets are important because buyers may solve the same problem in different ways. A hospital can buy stand-alone imaging AI, contract with a conventional teleradiology group, hire more in-house radiologists, or adopt workflow software without outsourcing interpretation. Imagen's positioning as an end-to-end diagnostic imaging partner, including teleradiology, on-site imaging equipment, and FDA-cleared AI software, suggests the company is competing against all of those alternatives to some extent, not just against other AI imaging startups [MedIndexer, retrieved 2026].

Regulatory and macro forces cut both ways. On the positive side, the company says it builds FDA-cleared AI and workflow tools, and it announced HITRUST Risk-based, 2-year Certification in August 2023, both of which matter in a category where provider buyers care about clinical validation, privacy, and enterprise compliance [Imagen, Aug 2023] [Imagen, retrieved Unknown]. On the constraining side, healthcare delivery remains operationally regulated and state-based, especially when the product involves physician practice, credentialing, and multi-state coverage. The public sources stop short of detailing Imagen's reimbursement exposure or licensure complexity, but its own multi-state and physician-led claims indicate those execution demands are likely material [Imagen Technologies Careers, November 2026] [Imagen Technologies, January 2026].

Company-stated, unverified -- This section relies heavily on company and recruiting materials for category definition and demand signals, with limited independent corroboration from Verified Market Research and MedIndexer.

Competitive Landscape

Competitive set

MIXED Imagen is positioned less like a pure imaging-software vendor and more like a managed radiology platform, which places it in competition with both AI imaging toolmakers and service-led diagnostic providers [Imagen, retrieved Unknown] [MedIndexer, retrieved 2026].

Company Positioning Stage / Funding Notable Differentiator Source
Imagen Technologies AI-enabled teleradiology platform combining remote radiologist coverage, clinical tools, and administrative support for health systems and physician groups Growth / Late Stage; over $200M raised according to company materials, including a reported $100M financing in November 2026 Vertically integrated model that combines physician labor, workflow software, and FDA-cleared AI tools inside one operating stack [Imagen Technologies Careers, November 2026] [Imagen, November 2026] [Imagen, retrieved Unknown]
AIRS Medical AI imaging software company Not established in the provided sources AI-centered positioning in medical imaging [Structured facts]
Subtle Medical AI imaging software company Not established in the provided sources AI-centered positioning in medical imaging [Structured facts]
Radiobotics Radiology AI company Not established in the provided sources Radiology-focused AI tooling [Structured facts]
Cerebriu Imaging and radiology AI company Not established in the provided sources Imaging workflow and AI orientation [Structured facts]
KUBRA Named competitor in the source set Not established in the provided sources Competitive relevance is named, but product overlap is not substantiated in the provided public materials [Structured facts]

The comparison table is directionally useful, but the evidence base is uneven. For Imagen, the public record in this dataset supports a service-plus-software model, with company materials describing teleradiology coverage, FDA-cleared AI, and administrative support [Imagen, retrieved Unknown] [Imagen Technologies Careers, November 2026].

The market appears to break into three practical groups. First are integrated radiology service providers, where Imagen sits by combining board-certified remote readers with workflow and support infrastructure [Imagen Technologies, January 2026] [MedIndexer, retrieved 2026]. Third are adjacent substitutes, namely incumbent hospital radiology departments and traditional outsourced teleradiology groups, which may not market themselves as AI companies but still compete for the same studies, contracts, and physician relationships, an inference supported by Imagen's stated focus on hospitals, health systems, and physician groups [Imagen, retrieved Unknown].

Imagen's clearest edge today is that it is not trying to win on algorithm performance alone. The company says it has built a physician-led practice supported by FDA-cleared AI and workflow tools, and public-facing materials point to operational metrics such as 2 million or more studies read annually, 200 or more specialists, 17-minute average STAT turnaround time, 99.5% service adherence, and 98% retention, though these figures are company-reported and not independently audited in this source set [Imagen, retrieved Unknown] [Ventureburn, retrieved 2026]. If those numbers hold, the defensibility comes from a combination of distributed clinical labor, workflow data, and recruiting scale, which is harder to displace than a single point solution. The durability of that edge is mixed, however, because much of it rests on execution in staffing, credentialing, and customer service, areas that are valuable but not permanently protected by regulation or model IP alone [Imagen Technologies Careers, November 2026] [Imagen Technologies, January 2026].

The exposure is equally clear. Imagen is also exposed where buyer proof matters most: the provided public materials include no named customer logos, buyer testimonials, or case studies, which weakens third-party validation relative to competitors that may enter deals with more visible reference accounts, according to the reputation flag in the source pack [PitchKitchen, 2026].

Over the next 18 months, the most plausible scenario is continued bifurcation between integrated service models and software enablers. Imagen is the likely winner if health systems continue prioritizing radiologist coverage, turnaround time, and administrative relief in one contract, because its model is built around that bundled value proposition and appears to be funded for expansion [Imagen Technologies Careers, November 2026] [Imagen, November 2026]. Subtle Medical is the likely winner if procurement shifts toward lighter-weight software purchases that preserve incumbent radiology relationships. The most exposed player under that scenario would be any integrated provider, including Imagen, whose public proof points remain mostly company-originated rather than independently referenced. That does not negate the strategy, but it does narrow the margin for error in competitive selling [PitchKitchen, 2026] [Imagen, retrieved Unknown].

Single unverified source -- Imagen's positioning is supported by company materials and one third-party directory, but the named competitor set is only partially substantiated in the provided public sources, and several comparative inferences are directional rather than independently corroborated.

Opportunity

PUBLIC

The prize here is unusually large if Imagen executes, because radiology is one of the few clinical workflows where labor, software, compliance, and throughput can plausibly be bundled into a single national operating layer rather than sold as point tools [Imagen, retrieved Unknown] [MedIndexer, retrieved 2026].

The headline opportunity is straightforward: Imagen could become a scaled diagnostic imaging platform for community providers, hospitals, and health systems that want radiology coverage, workflow software, and AI tooling from one vendor rather than stitching those pieces together themselves [Imagen, retrieved Unknown] [MedIndexer, retrieved 2026]. That outcome is not yet proven, but it is more reachable than a pure software vision would be because the company already presents as a services-plus-software platform, with remote radiologist coverage, administrative support, AI-enabled workflow, and a reported footprint across 28 states and more than 2 million studies annually [Imagen Technologies, January 2026] [Ventureburn, retrieved 2026]. The funding base also matters. Company materials say Imagen has raised over $200 million, while round databases point to at least four disclosed financings including a $100 million round announced in November 2026, which suggests enough capital to keep building both clinical capacity and proprietary tooling if execution holds [Imagen Technologies Careers, November 2026] [Imagen, November 2026] [CB Insights, retrieved 2026] [Tracxn, retrieved 2026].

That upside breaks into a few distinct paths to scale, and each path depends on a different catalyst.

Scenario What happens Catalyst Why it's plausible
National outsourced radiology layer Imagen becomes a preferred external imaging partner for independent practices, hospitals, and health systems that need coverage, faster turnaround, and subspecialty reads Converting its current multistate footprint into deeper enterprise contracting and wider state coverage Imagen markets an end-to-end diagnostic imaging platform to hospitals, health systems, and physician groups, and public materials cite operations across 28 states with more than 2 million studies annually [Imagen, retrieved Unknown] [MedIndexer, retrieved 2026] [Ventureburn, retrieved 2026]
AI-enabled practice operating system Imagen uses its physician-led practice plus workflow software to become the default software-and-service stack for radiology groups, with AI embedded into QA, prioritization, and interpretation support Continued FDA clearances and tighter integration of in-house AI into daily reading workflows The company says it builds FDA-cleared AI and workflow tools, uses proprietary AI to monitor report quality and clinician performance, and positions the practice as vertically integrated rather than as a standalone algorithm vendor [Imagen, retrieved Unknown] [Imagen AI, retrieved 2026] [Imagen Technologies Careers, November 2026]
Data advantage into clinical infrastructure Imagen turns high study volume and radiologist usage into a compounding model-development engine, improving products and making the platform harder to replace over time Sustained access to large imaging-study volumes tied to practice operations The company cites more than 2 million studies read annually and announced financing linked to securing up to 150 million new imaging studies for AI development, which, if realized, would materially expand training and validation inputs [Imagen, retrieved Unknown] [Imagen, November 2026]

The compounding logic is the most important part of the upside. If Imagen wins an account through service reliability and turnaround time, it can layer in more workflow software, more AI-assisted reading, and more administrative integration over time, raising switching costs beyond a normal teleradiology contract [Imagen, retrieved Unknown] [Imagen Technologies, January 2026]. Company-reported operating signals point in that direction: 99.5% service adherence, less than 1% addendum rate, 98% retention, 90% annual radiologist retention, and a reported base of 200-plus specialists [Imagen, retrieved Unknown]. Those are company claims, so they need independent diligence, but if directionally accurate they describe the beginnings of a flywheel in which volume attracts radiologists, radiologists improve coverage and subspecialty depth, better service wins more customers, and higher study volume produces more data for workflow and AI refinement [Imagen, retrieved Unknown] [Imagen AI, retrieved 2026].

The size of the win is best framed as scenario analysis, not a forecast. Public comparables in radiology AI and imaging infrastructure are imperfect because Imagen blends services with software, but if the company becomes a national imaging operations platform with durable software attachment, the relevant outcome is not a niche tool vendor. In that case, a plausible ceiling is a strategic or public-market valuation associated with scaled healthcare infrastructure software rather than point-solution AI, especially given disclosed funding north of $200 million and the stated ambition to expand from 22 states and 2.7 million patients in 2025 to more than 35 states and over 5 million patients annually by 2027 [Imagen Technologies Careers, November 2026] [Imagen, November 2026]. Without a source-grounded public comparable in the provided materials, the cleaner formulation is this: if the national outsourced-radiology-layer scenario plays out, Imagen could be worth several multiples of invested capital at exit as a category-level platform asset (scenario, not a forecast), but that case rests on proving customer adoption and economic durability beyond company-published operating metrics [Imagen Technologies Careers, November 2026] [Ventureburn, retrieved 2026].

Company-stated, unverified -- This section relies materially on company websites, careers pages, and company-announced metrics, with partial corroboration from MedIndexer, Ventureburn, CB Insights, and Tracxn.

Sources

Public sources

  1. [Crunchbase] Imagen - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/imagentechnologies

  2. [Crunchbase, 2026] Rob Lindsey - Co-Founder & CTO @ Imagen Technologies | https://www.crunchbase.com/person/rob-lindsey

  3. [Imagen, November 2026] Imagen Raises $100 Million to Build the Best Place for Radiologists to Practice Their Craft | https://imagen.ai/newsroom/imagen-raises-100-million-in-capital-secures-up-to-150-million-new-imaging-studies-for-ai-development-that-continues-to-make-imagen-the-best-place-for-radiologists-to-practice-their-craft

  4. [Imagen Technologies Careers, November 2026] Imagen Technologies Careers | https://jobs.gem.com/imagen-technologies

  5. [Imagen Technologies, January 2026] Imagen Technologies, January 2026 | https://job-boards.greenhouse.io/imagentechnologies/jobs/8364309002

  6. [Imagen Technologies, October 2025] Imagen Technologies, October 2025 | https://job-boards.greenhouse.io/imagentechnologies/jobs/8214251002?gh_src=vclx7mah2us

  7. [Imagen, August 2023] Company - Imagen | https://imagen.ai/company/

  8. [Imagen] Imagen | AI-Powered Radiology & Diagnostic Imaging Platform | https://imagen.ai/

  9. [LinkedIn] Imagen Technologies | LinkedIn | https://www.linkedin.com/company/imagen-technologies

Articles about Imagen Technologies

View on Startuply.vc